Royalty Pharma Company Description

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes.

The company was founded in 1996 and is based in New York, New York.

Royalty Pharma plc

Country	United Kingdom
Founded	1996
Industry	Pharmaceutical Preparations
CEO	Pablo Legorreta

Contact Details

Address: 110 East 59th Street New York, 10022 United States
Phone	212 883 0200
Website	royaltypharma.com

Stock Details

Ticker Symbol	RPD
Exchange	Frankfurt Stock Exchange
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2834

Key Executives

Name	Position
Pablo Legorreta	Chief Executive Officer
Terrance Coyne	Chief Financial Officer
George Grofik	Head of Investor Relations